Watchlist Price Alert

NeuroBo Pharmaceuticals I... (NRBO)

NASDAQ: NRBO · Real-Time Price · USD

2.36

null (null%)

At close: Nov 27, 2024, 9:00 PM

NeuroBo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-12.47M	-13.97M	-15.28M	-29.68M	-21.31M	-23.64M	-33.41M	-14.59M
Depreciation & Amortization	6K	20K	48K	46K	17K	346K	137K	-17K
Stock-Based Compensation	222K	854.00	662.00	699.00	118.00	4.13M	5.27M	1.72M
Other Working Capital	4.28M	-966K	578K	-314K	1.79M	-770K	-903K	441K
Other Non-Cash Items	-2.95M	2.55M	24K	17.36M	12.28M	346K	137K	200K
Deferred Income Tax	n/a	n/a	n/a	n/a	1.11M	-346K	-137K	-276K
Change in Working Capital	4.4M	-1.17M	-584K	809K	744K	-2.75M	1.1M	1.92M
Operating Cash Flow	-10.8M	-11.71M	-15.13M	-10.76M	-7.04M	-21.91M	-26.9M	-11.04M
Capital Expenditures	-50K	n/a	-3K	-4K	-214K	-3K	n/a	n/a
Cash Acquisitions	n/a	8K	-583	180K	1.52M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	8.00	-582.42K	-107K	-7.37M	n/a	n/a	n/a
Investing Cash Flow	-50K	8K	-586K	69K	-6.06M	-3K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	500K	10M	5.15M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-80K	-35.82M	-1.97M	-642K	-73K	-25.2M	-1.2M	-10K
Financial Cash Flow	-80K	28.68K	22.03M	6.86M	24.17M	22.39M	21.34M	31.46M
Net Cash Flow	-10.93M	16.98M	6.3M	-3.83M	11.08M	481K	-5.56M	20.41M
Free Cash Flow	-10.85M	-11.71M	-15.14M	-10.77M	-7.25M	-21.91M	-26.9M	-11.04M